Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, USA.
Department of Geriatrics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, 72205, USA.
AAPS J. 2019 Dec 18;22(1):14. doi: 10.1208/s12248-019-0399-6.
Aurora kinase B (AKB), a Ser/Thr kinase that plays a crucial role in mitosis, is overexpressed in several cancers. Clinical inhibitors targeting AKB bind to the active DFG "in" conformation of the kinase. It would be beneficial, however, to understand if AKB is susceptible to type II kinase inhibitors that bind to the inactive, DFG "out" conformation, since type II inhibitors achieve higher kinome selectivity and higher potency in vivo. The DFG "out" conformation of AKB is not yet experimentally determined which makes the design of type II inhibitors exceedingly difficult. An alternate approach is to simulate the DFG "out" conformation from the experimentally determined DFG "in" conformation using atomistic molecular dynamics (MD) simulation. In this work, we employed metadynamics (MTD) approach to simulate the DFG "out" conformation of AKB by choosing the appropriate collective variables. We examined structural changes during the DFG-flip and determined the interactions crucial to stabilize the kinase in active and inactive states. Interestingly, the MTD approach also identified a unique transition state (DFG "up"), which can be targeted by small molecule inhibitors. Structural insights about these conformations is essential for structure-guided design of next-generation AKB inhibitors. This work also emphasizes the usefulness of MTD simulations in predicting macromolecular conformational changes at reduced computational costs.
极光激酶 B(AKB)是一种丝氨酸/苏氨酸激酶,在有丝分裂中发挥着关键作用,在几种癌症中过度表达。针对 AKB 的临床抑制剂与激酶的活性 DFG“在”构象结合。然而,如果了解 AKB 是否容易受到与非活性 DFG“出”构象结合的 II 型激酶抑制剂的影响将是有益的,因为 II 型抑制剂在体内实现了更高的激酶组选择性和更高的效力。AKB 的 DFG“出”构象尚未通过实验确定,这使得 II 型抑制剂的设计变得非常困难。一种替代方法是使用原子分子动力学(MD)模拟从实验确定的 DFG“在”构象中模拟 DFG“出”构象。在这项工作中,我们通过选择适当的集体变量,使用元动力学(MTD)方法来模拟 AKB 的 DFG“出”构象。我们检查了 DFG 翻转过程中的结构变化,并确定了稳定激酶在活性和非活性状态下的关键相互作用。有趣的是,MTD 方法还确定了一个独特的过渡态(DFG“向上”),小分子抑制剂可以靶向该过渡态。这些构象的结构见解对于基于结构的下一代 AKB 抑制剂的设计至关重要。这项工作还强调了 MTD 模拟在降低计算成本的情况下预测大分子构象变化的有用性。